Piper Sandler analyst Jessica Tassan lowered the firm’s price target on Cigna (CI) to $348 from $394 and keeps an Overweight rating on the shares. Elevated incidence and acuity of high-cost claimants in Stop-Loss drove a large Q4 consolidated earnings miss, the firm notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI: